Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Oncology

Respiratory

Inflammation
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Oncology

Giotrif

Format

Sort by

Reset all filters

2:20

RWDRI||Real-World Effectiveness of Sequential GIOTRIF® & osimertinib - Data from GIOTAG and RESET studies

Watch-now Opens in new tab

PDF

SEREAL||RealGiDo: Impact of GIOTRIF® dose adjustment in the real-world setting

Download Opens in new tab

PDF

GIOTRIF® maintains efficacy despite dose modification

Download Opens in new tab

PDF

SEREAL||Management of GIOTRIF® adverse events in the real world

Download Opens in new tab

strategies-optimise-management-egfr-tki-related-side-effects_0

PDF

Strategies to optimise the management of EGFR TKI-related side effects

Download Opens in new tab

PDF

Sequential treatment afatinib

Download Opens in new tab

Pagination

Load More

Home
Resources
Oncology

Sitemap

Therapeutic Area

Resources

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Singapore. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.